打一劑 HPV 疫苗，效果和兩劑一樣好？NEJM 五年、兩萬人臨床試驗解讀

https://www.nejm.org/doi/full/10.1056... If I told you that one dose of the HPV vaccine might be as effective as two doses, and this isn't a small study or observational data, but a large-scale randomized clinical trial published in the New England Journal of Medicine (NEJM), tracking over 20,000 participants for five years, wouldn't you think this could potentially change global public health policy? In this video, I will guide you through a comprehensive understanding of this important study, which could rewrite HPV vaccination strategies, from the perspectives of doctors and researchers. 📌 Why is the research background important? Only about 27% of adolescent girls worldwide have completed HPV vaccination. Over 90% of cervical cancer deaths occur in resource-constrained countries. The problem isn't that vaccines are ineffective, but that they are unaffordable, unavailable, and insufficient. If one dose can provide nearly the protection of two doses, doesn't that mean more people can be protected? 📊 What did this NEJM study do? Over 20,000 women aged 12–16 in Costa Rica Compared bivalent and nonavalent HPV vaccines One dose vs. two doses Followed up HPV16/18 persistent infection rates for 5 years Used a non-inferiority trial design, focusing on practical public health implications 📈 What were the key results? One dose of the vaccine provided approximately 97–98% protection against HPV16/18 No significant difference compared to two doses No decline in protective efficacy was observed over the five-year follow-up period Safety profile was consistent with existing global HPV vaccine experience 🌍 What does this mean? This is not about "lowering standards," but about using science to achieve higher coverage. This has significant implications for low-income countries and public health policies. The WHO's single-dose recommendation is now supported by the strongest level of evidence from randomized trials. ⚠️ Important Reminder This is a public health-level research conclusion, which does not mean "everyone only needs one dose." Age, immune status, and policy design still need to be considered holistically. 📌 If you only need to remember one thing: 👉 In preventing the most critical carcinogenic HPV types (16/18), one dose of HPV vaccine is almost as effective as two doses. If you are considering whether to vaccinate your child against HPV, or are concerned about the future policy direction in Taiwan, please share your thoughts in the comments section, and feel free to share this video with parents who might need it. Remember to like, subscribe, and turn on notifications, we'll continue to explain medical research clearly next time.